Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1781 (LINC01781)

Target: LINC01781
Molecular classification: Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)

Overview

Long intergenic non-protein coding RNA 1781 (LINC01781) is a human long non-coding RNA (lncRNA), specifically classified as a long intergenic non-coding RNA (lincRNA). LINC01781 is a non-protein coding gene, meaning it does not encode a protein but rather functions as an RNA molecule. Like other lincRNAs, LINC01781 is thought to participate in the regulation of gene expression, possibly through modulation of chromatin, transcription, or other epigenetic means. LINC01781 has been reported to be downregulated in pancreatic ductal adenocarcinoma (PDAC) characterized by high glycolytic activity; however, its precise biological role and mechanism in health or disease are not yet well established. There are currently no drugs, diagnostic biomarkers, or targeted therapies associated with LINC01781, and it is not considered a traditional therapeutic target such as a receptor or enzyme.

Other names: LINC01781

Biological functions

Gene regulation (likely through transcriptional and/or epigenetic regulation, based on its class)possible involvement in metabolic phenotype modulation (inferred from related lincRNA studies, not specific for LINC01781)

Disease associations

Cancer (downregulated in glycolysis-high pancreatic ductal adenocarcinoma (PDAC) and thus may be implicated in cancer metabolism)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1781 (LINC01781).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1781 (LINC01781).

Explore the full profile